The Living Guidelines: UA/NSTEMI Recommendations for Beta Blockers Therapy Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. Beta blockers are indicated for all patients recovering from UA/NSTEMI unless contraindicated. Treatment should begin within a few days of the event, if not initiated acutely, and should be continued indefinitely. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class I Recommendation 1 for Beta Blockers should be: CLASS I CLASS IIa CLASS IIb CLASS III

2. Patients recovering from UA/NSTEMI with moderate or severe LV failure should receive beta-blocker therapy with a gradual titration scheme. (Level of Evidence: B)

 UA/NSTEMI Guidelines Class I Recommendation 1 for Beta Blockers should be: CLASS I CLASS IIa CLASS IIb CLASS III